237 related articles for article (PubMed ID: 18361932)
1. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.
Tamaki S; Sanefuzi N; Kawakami M; Aoki K; Imai Y; Yamanaka Y; Yamamoto K; Ishitani A; Hatake K; Kirita T
Hum Immunol; 2008 Feb; 69(2):88-93. PubMed ID: 18361932
[TBL] [Abstract][Full Text] [Related]
2. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma.
Tamaki S; Kawakami M; Yamanaka Y; Shimomura H; Imai Y; Ishida J; Yamamoto K; Ishitani A; Hatake K; Kirita T
Clin Immunol; 2009 Mar; 130(3):331-7. PubMed ID: 18951065
[TBL] [Abstract][Full Text] [Related]
3. Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma.
Tamaki S; Kawakami M; Ishitani A; Kawashima W; Kasuda S; Yamanaka Y; Shimomura H; Imai Y; Nakagawa Y; Hatake K; Kirita T
Anticancer Res; 2010 Oct; 30(10):4097-101. PubMed ID: 21036725
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
5. [Soluble major histocompatibility complex class I-related chain A in sera of patients with oral squamous cell carcinoma].
Li C; Shi F; Yang D; Wang J; Jian X; Jiang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):168-72. PubMed ID: 22561434
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Ohkawa K; Miyagi T; Hiramatsu N; Kanto T; Kasugai T; Katayama K; Kato M; Hayashi N
Cancer Sci; 2008 Aug; 99(8):1643-9. PubMed ID: 18754878
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
9. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
10. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
Rebmann V; Schütt P; Brandhorst D; Opalka B; Moritz T; Nowrousian MR; Grosse-Wilde H
Clin Immunol; 2007 Apr; 123(1):114-20. PubMed ID: 17218152
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy.
Chang SM; Xing RD; Zhang FM; Duan YQ
Oral Dis; 2009 Nov; 15(8):570-2. PubMed ID: 19563418
[TBL] [Abstract][Full Text] [Related]
12. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
[TBL] [Abstract][Full Text] [Related]
13. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance.
Zhao D; Pan J; Li XQ; Wang XY; Tang C; Xuan M
J Oral Pathol Med; 2008 Nov; 37(10):616-25. PubMed ID: 19012622
[TBL] [Abstract][Full Text] [Related]
15. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
16. MICA and MICB overexpression in oral squamous cell carcinoma.
Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and CD34 expression as a predictor of recurrence in oral squamous cell carcinoma.
Kademani D; Lewis JT; Lamb DH; Rallis DJ; Harrington JR
J Oral Maxillofac Surg; 2009 Sep; 67(9):1800-5. PubMed ID: 19686913
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
19. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]